Literature DB >> 18625279

Government financing for health and specific national budget lines: the case of vaccines and immunization.

Patrick Lydon1, Pa Lamin Beyai, Irtaza Chaudhri, Niyazi Cakmak, Alexis Satoulou, Laure Dumolard.   

Abstract

A long standing question related to immunization financing and sustainability has been whether the existence of a specific line item for vaccines purchasing within the national health budget can contribute significantly to increasing national government financing of vaccines and routine immunizations. Based on immunization financing indicators from 185 countries collected through the joint WHO and UNICEF monitoring system, this paper attempts to answer this policy question. The study will present findings related to the status of countries that have such specific budget lines for purchasing vaccines and the levels of national budgetary allocation to the financing of vaccines and immunizations, particularly in low-income countries. The analysis shows evidence that the existence ofa specific line in the national budget is associated with increased governmental budget allocations for vaccines and routine immunization financing.

Mesh:

Substances:

Year:  2008        PMID: 18625279     DOI: 10.1016/j.vaccine.2008.06.090

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

Review 1.  Pricing of new vaccines.

Authors:  Bruce Y Lee; Sarah M McGlone
Journal:  Hum Vaccin       Date:  2010-08

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

Review 3.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

4.  Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.

Authors:  Sun-Young Kim; Steven Sweet; Joshua Chang; Sue J Goldie
Journal:  BMC Infect Dis       Date:  2011-06-16       Impact factor: 3.090

5.  Budget line items for immunization in 33 African countries.

Authors:  Ulla K Griffiths; Jennifer Asman; Alex Adjagba; Marina Yo; James O Oguta; Chloe Cho
Journal:  Health Policy Plan       Date:  2020-08-01       Impact factor: 3.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.